What does GreyBird Ventures invest in?
GreyBird Ventures invests most often at Series A and Series C (100% of the rounds on record), in sectors such as Pharma, Therapeutics and Celle Therapy.

United States · Investor
Last cheque observed Aug 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietVC firm
2 rounds on record
Mostly Series A and Series C: 100% of its rounds
Sole investor in 1 rounds, median $3.0M
Investments in unique diagnostic technologies for the era of precision medicineFrom their own website
Every round we can evidence, newest first2 appearances
1 round
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
From their own portfolio page (on their website)
Dariotis Design
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
GreyBird Ventures invests most often at Series A and Series C (100% of the rounds on record), in sectors such as Pharma, Therapeutics and Celle Therapy.
2 investments on record, 0 of them in the last 12 months. The most recent was in Aug 2019.
Its most recent investments on record: GNA Biosolutions (Series C, Aug 2019) and Ceres Nonosciences (Series A, Feb 2017).
The median round it joins is $8.3M.
No investments in the last 12 months; the latest was in Aug 2019.
GreyBird Ventures is a VC firm based in Malvern, United States.
GreyBird Ventures was founded in 2014.
From 3 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it